Lecture 19 Tumours Flashcards
Tumour
Clinically detectable lump or swelling
Neoplasm
Type of tumour
Abnormal growth of cells that persists after the initial stimulus is removed
Malignant neoplasms
An abnormal growth of cells that persists even after the initial stimulus is removed and invades into surrounding tissue with potential to spread to distal sites
Vulval cancers
Uncommon
3% of female cancers
Arise in older patients mid 80s
Most common type: squamous cell carcinoma (vulva is keratinised squamous cell)
- basal cell carcinoma
- melanoma
Clinical features of a vulval cancer
Lumps
Ulceration
Skin changes e.g. hyperpigmentation in a melanoma
Associated with long-standing inflammatory conditions such as lichen sclerosus
Vulval intraepithelial neoplasia
In situ precursor of vulval squamous cell carcinoma
Atypical cells
Basement membrane intact
How does vulval cancer spread?
Direct extension:
- anus
- vagina
- bladder
Lymph nodes:
- Inguinal
- Iliac
- para aortic
Distant metastases
- lungs
- liver
Parts of the cervix and associated cancer
Inner cervix : endocervix : glandular epithelium: adenocarcinoma
Outer cervix: ectocervix: stratifies squamous epithelium: SCC (most common)
Transformation zone
Meta plasma occurs between the 2 epithelial cell types
Risk of dysplasia is higher therefore risk of cancer is higher
HPV and cervical cancer
HPV causes infection of the metaplastic squamous cells in the transformation zone causing increased proliferation
- Infect transformation zone
- Produce viral proteins E6 and E7
- Inactivate tumour suppressor genes (p53 and Rb)
- Uncontrolled cellular division
- CIN
Dysplasia
Pre - neoplastic alteration in which cells show DISORDERED tissue organisation
Change is reversible
Cervical intraepithelial neoplasia
Dysplasia
Confined to the cervical epithelium in situ
Caused by HPV
SCC can develop
CIN 1, 2, 3 and SCC
CIN 1 : Mild dysplasia - bottom 1/3rd
CIN 2: Moderate dysplasia - affects bottom 2/3rds
CIN 3: Severe dysplasia - full thickness
SCC: invasive carcinoma - breaks through the basement membrane
Risk factors for CIN
Increased risk of exposure to HPV:
- HPV sexual partners
- Multiple partners
- Early age of first intercourse
Early first pregnancy Multiple births Smoking Low socioeconomic status Immunosuppression
Treatment for CIN 1
Often regresses spontaneously as dysplasia is reversible
Therefore follow up cervical smear in 1 year
CIN 2 and 3 treatment
Large loop excision of transition zone
Cervical cancer screening
- Brush used to scrape cells from the transformation zone
- Tested for HPV
- If +ve, cells are looked at under the microscope
When to do cervical screen
Aged 25 - 49 - every 3 years
Aged 50 - 64 - every 5 years
Over 65 - if recent anomaly
Dysplastic cells
Large nuclei
Pleomorphism
Irregular membrane
Mitotic bodies
Vaccination against HPV
Gardasil- for HPV 6, 11, 16, 18 strains
Given aged 12 - 13
Protects from cervical, oral, vulval and anal cancers
Invasive cervical cell carcinoma presentation
Bleeding
- post coital
- inter menstrual
- post menstrual
Mass
+ve screening
Invasive cervical cancer spread
Stage 1 : confined to cervix
Stage 2: beyond cervix but not to pelvic wall or lower 1/3rd of vagina
Stage 3: Disease to pelvic wall or lower 1/3rd of vagina
Stage 4: Invades bladder, rectum it metastasis
Treatment of invasive cervical cancer (3)
Hysterectomy
Lymph node dissection
- iliac
- aortic
Chemoradiotherapy